Artikel ; Online: Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom.
2015 Band 18, Heft 6, Seite(n) 800–809
Abstract: Background: Seven drugs are licensed for the treatment of chronic hepatitis B (CHB) in the United Kingdom. Which initial treatment, secondary therapy, and whether antivirals should be given alone or in combination are questions of considerable ... ...
Abstract | Background: Seven drugs are licensed for the treatment of chronic hepatitis B (CHB) in the United Kingdom. Which initial treatment, secondary therapy, and whether antivirals should be given alone or in combination are questions of considerable uncertainty. Objective: The aim of this model was to undertake a comprehensive economic evaluation of all antiviral treatments for CHB to recommend the most cost-effective therapeutic sequence. Methods: We developed a probabilistic Markov model to compare the cost-effectiveness of all clinically relevant antiviral treatment sequences for nucleos(t)ide-naive adults with hepatitis B e-antigen (HBeAg)-positive or HBeAg-negative CHB. Relative rates of HBeAg seroconversion and viral suppression were obtained from a network meta-analysis. Data on mortality, antiviral drug resistance, durability of response, adverse events, and costs were obtained from published literature. Results are reported in terms of lifetime costs, quality-adjusted life-years (QALYs), and expected net benefit. Results: In the base-case analysis, pegylated interferon alpha-2a (peg-IFN α-2a) followed by tenofovir disoproxil fumarate was most effective and cost-effective in HBeAg-positive patients, with a cost of £7488 per QALY gained compared with no treatment. In HBeAg-negative patients, peg-IFN α-2a followed by entecavir was most effective and cost-effective, with a cost of £6981 per QALY gained. The model was robust to a wide range of sensitivity analyses. Conclusions: Peg-IFN α-2a followed by tenofovir disoproxil fumarate or entecavir is the most effective antiviral treatment strategy for people with both variants of CHB. At a cost of less than £10,000 per QALY gained, these sequences are considered cost-effective in England and Wales. The results of this analysis were used to inform 2013 National Institute for Health and Care Excellence guideline recommendations. |
---|---|
Mesh-Begriff(e) | Adult ; Antiviral Agents/economics ; Antiviral Agents/therapeutic use ; Biomarkers/blood ; Comparative Effectiveness Research ; Cost-Benefit Analysis ; Decision Support Techniques ; Drug Costs ; Drug Substitution/economics ; Drug Therapy, Combination/economics ; Female ; Hepatitis B e Antigens/blood ; Hepatitis B, Chronic/blood ; Hepatitis B, Chronic/diagnosis ; Hepatitis B, Chronic/drug therapy ; Hepatitis B, Chronic/economics ; Humans ; Male ; Markov Chains ; Models, Economic ; Patient Selection ; Practice Guidelines as Topic ; Probability ; Quality of Life ; Quality-Adjusted Life Years ; State Medicine/economics ; Time Factors ; Treatment Outcome ; United Kingdom ; Young Adult |
Chemische Substanzen | Antiviral Agents ; Biomarkers ; Hepatitis B e Antigens |
Sprache | Englisch |
Erscheinungsdatum | 2015-09 |
Erscheinungsland | United States |
Dokumenttyp | Comparative Study ; Journal Article ; Meta-Analysis |
ZDB-ID | 1471745-1 |
ISSN | 1524-4733 ; 1098-3015 |
ISSN (online) | 1524-4733 |
ISSN | 1098-3015 |
DOI | 10.1016/j.jval.2015.05.007 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 5904: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.